Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases

Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases

Aims: Our goal was to expand the spectrum of clinico-radiologic characteristics and the possible therapeutic choices in patients with tumefactive demyelinating lesions (TDLs). Methods: A retrospective analysis of 50 patients with at least one TDL was performed at an academic neurology center (2008–2...

Full description

Bibliographic Details
Main Authors:	Aigli G. Vakrakou, Dimitrios Tzanetakos, Maria-Eleptheria Evangelopoulos, Theodore Argyrakos, John S. Tzartos, Maria Anagnostouli, Elissavet Andreadou, Georgios Koutsis, Georgios Velonakis, Panagiotis Toulas, Elias Gialafos, Antonios Dimitrakopoulos, Erasmia Psimenou, Leonidas Stefanis, Constantinos Kilidireas
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-05-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/17562864211006503

Similar Items

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature
by: Aigli G. Vakrakou, et al.
Published: (2020-06-01)

Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis
by: Dimitrios Tzanetakos, et al.
Published: (2022-10-01)

A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes
by: A. G. Vakrakou, et al.
Published: (2018-10-01)

Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis
by: Aigli G. Vakrakou, et al.
Published: (2023-01-01)

An Updated Evaluation of Intrathecal IgG Synthesis Markers in Relation to Oligoclonal Bands
by: Fotini Boufidou, et al.
Published: (2023-01-01)

Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination
by: Maria Pechlivanidou, et al.
Published: (2023-08-01)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
by: Aigli G. Vakrakou, et al.
Published: (2023-07-01)

The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data
by: Aigli G. Vakrakou, et al.
Published: (2022-07-01)

Recurrent tumefactive demyelinating lesions in an elderly woman
by: Erika L. Weil, MD, et al.
Published: (2022-12-01)

Tumefactive Brain Demyelination Accompanying MADSAM Neuropathy
by: Şefik Evren Erdener, et al.
Published: (2015-09-01)

Isolated medullary tumefactive demyelination masquerading as tumor
by: Sushant Agarwal, et al.
Published: (2022-01-01)

Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm
by: Tom George, et al.
Published: (2016-03-01)

A case of relapsing-remitting tumefactive demyelination
by: Ankur Wadhwa, et al.
Published: (2019-01-01)

Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review
by: Konstantina Yiannopoulou, et al.
Published: (2023-06-01)

Case Report: Paraneoplastic Tumefactive Demyelination Associated With Seminoma
by: Wataru Shiraishi, et al.
Published: (2022-07-01)

Tumefactive demyelinating lesions: A Clinicopathological correlative study
by: R Neelima, et al.
Published: (2012-01-01)

Tumefactive demyelinating lesions: a retrospective cohort study in Thailand
by: Tatchaporn Ongphichetmetha, et al.
Published: (2024-01-01)

Tumefactive demyelination—A rare presentation of Anti-MOG Syndrome
by: Sesh Sivadasan, et al.
Published: (2022-01-01)

Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions
by: Yajing Zhang, et al.
Published: (2023-05-01)

Neuroimaging features of tumefactive demyelinating lesions: A rare case report
by: Febyan, et al.
Published: (2020-01-01)

Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report
by: Sakas Damianos, et al.
Published: (2011-06-01)

Author Correction: Tumefactive demyelinating lesions: a retrospective cohort study in Thailand
by: Tatchaporn Ongphichetmetha, et al.
Published: (2024-03-01)

Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients
by: Mahboubeh Fereidan‐Esfahani, et al.
Published: (2023-09-01)

Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A
by: Victor Oliveira Araújo, et al.
Published: (2022-11-01)

Tumefactive demyelination versus tumor; A diagnostic dilemma: Role of electron microscopy
by: Paresh Doshi, et al.
Published: (2018-01-01)

Anti-Myelin Oligodendrocyte Glycoprotein-Associated Disease with Recurrent Tumefactive Demyelinating Lesions
by: Hüseyin Nezih Ozdemir, et al.
Published: (2021-01-01)

Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
by: Neuroimmunology Group of Neurology Branch of Chinese Medical Association, et al.
Published: (2017-01-01)

A rare case of tumefactive demyelination of brain: A case report and literature review
by: Pugazhendi Inban, et al.
Published: (2023-12-01)

Corrigendum: Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
Published: (2017-01-01)

Phenotyping variants of tumefactive demyelinating lesions according to clinical and radiological features—A case series
by: Thérèse Boyle, et al.
Published: (2023-02-01)

Central nervous system tumefactive demyelinating lesions: Risk factors of relapse and follow-up observations
by: Xinnan Li, et al.
Published: (2022-12-01)

Magnetic resonance imaging in five patients with a tumefactive demyelinating lesion in the central nervous system
by: HELGA C. ALMEIDA SILVA, et al.
Published: (1999-12-01)

Deep Learning With Data Enhancement for the Differentiation of Solitary and Multiple Cerebral Glioblastoma, Lymphoma, and Tumefactive Demyelinating Lesion
by: Yu Zhang, et al.
Published: (2021-08-01)

Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient’s COVID-19 Infection
by: Nikolaos Markoglou, et al.
Published: (2022-11-01)

Integrative and comparative single-cell analysis reveals transcriptomic difference between human tumefactive demyelinating lesion and glioma
by: Xiao-Yong Chen, et al.
Published: (2022-09-01)

Comment on: Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases
by: Tommaso Nicoletti, et al.
Published: (2021-10-01)

Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma
by: Chenjing Sun, et al.
Published: (2022-08-01)

Tuméfaction gingivale chronique
by: Marielle Cerci, et al.
Published: (2020-10-01)

Tumefactive multiple sclerosis
by: Michael Gregorio Ortega-Sierra, et al.
Published: (2021-12-01)

Tumefactive multiple sclerosis
by: Michael Gregorio Ortega-Sierra, et al.
Published: (2021-12-01)